5
Clinical Trials associated with Antigen Pulsed Dendritic Cells(Shanghai Hisun Biotechnology)抗原致敏的人树突状细胞(APDC) 治疗转移性结直肠癌的III期临床研究
[Translation] Phase III clinical study of antigen-sensitized human dendritic cells (APDC) in the treatment of metastatic colorectal cancer
比较APDC联合5-Fu/LV+奥沙利铂与单用5-Fu/LV+奥沙利铂治疗转移性结直肠癌(mCRC)患者的无进展生存期(Progression Free Survival,PFS)及比较两组的安全性。
[Translation] To compare the progression-free survival (PFS) of APDC combined with 5-Fu/LV+oxaliplatin and 5-Fu/LV+oxaliplatin alone in the treatment of patients with metastatic colorectal cancer (mCRC), and to compare the safety of the two groups.
/ CompletedNot ApplicableIIT The phase I study of the combined immunotherapy using alpha-galactosylceramide pulsed antigen presenting cells and tumor-specific peptide pulsed dendritic cells for patients with advanced head and neck mucosal melanoma - The phase I study with alpha-GalCer pulsed APCs and tumor peptide pulsed DCs for head and neck mucosal melanoma
Start Date19 Aug 2013 |
Sponsor / Collaborator- |
Randomized phase II study with or without adjuvant immunotherapy of alpha-GalCer-pulsed dendritic cells in the patients with completely resected stage II-IIIA non-small cell lung cancer - Randomized phase II of adjuvant immunotherapy using alpha-GalCer-pulsed dendritic cells in completely resected stage II-IIIA non-small cell lung cancer (RADCLC)
Start Date22 Mar 2013 |
Sponsor / Collaborator- |
100 Clinical Results associated with Antigen Pulsed Dendritic Cells(Shanghai Hisun Biotechnology)
100 Translational Medicine associated with Antigen Pulsed Dendritic Cells(Shanghai Hisun Biotechnology)
100 Patents (Medical) associated with Antigen Pulsed Dendritic Cells(Shanghai Hisun Biotechnology)
100 Deals associated with Antigen Pulsed Dendritic Cells(Shanghai Hisun Biotechnology)